INEFFECTIVE AGAINST OMICRON, TREATMENTS WITHDRAWN
Health authorities on Wednesday significantly restricted the range of synthetic antibody treatments, noting that some were not effective enough against the Omicron variant. To treat an already declared Covid, none of the three treatments available so far is effective if the infection is due to the Omicron variant, the Medicines Agency (ANSM) said in a press release. Only one, AstraZeneca Evusheld, can be used to prevent infection with this variant.
Until recently, three antibody treatments were authorized in France: Ronapreve by Roche, the bamlanivimab / etesivimab combination by Eli Lilly and, more recently, Evusheld. These treatments are given little because they are heavy to administer since they require an intravenous injection. They are aimed at specific categories of patients.